Description
Wegovy: The Best-Selling Weight Loss Injection in Europe
Wegovy (active ingredient: semaglutide) is a once-weekly injection that has transformed prescription weight loss treatment in Europe. Manufactured by Novo Nordisk and approved by the European Medicines Agency (EMA) specifically for chronic weight management, Wegovy delivers an average weight reduction of 14.9% over 68 weeks in clinical trials — a result that established the modern GLP-1 era. At EU Slim Store, Wegovy is prescribed by Dutch BIG-registered doctors after a free online consultation and dispensed from our IGJ-registered Netherlands pharmacy.
How Wegovy Works
Wegovy contains semaglutide, a synthetic version of GLP-1 (glucagon-like peptide 1), a hormone your gut naturally releases after eating. Semaglutide binds to GLP-1 receptors throughout your body and acts in three ways:
- Slows gastric emptying — food remains in your stomach longer, prolonging fullness
- Reduces appetite signals in the brain’s hypothalamus and reward circuits
- Improves insulin response — helping stabilise blood sugar after meals
The result: you eat less without conscious effort, cravings reduce, and your body utilises fuel more efficiently. Patients typically describe a quiet but profound change — food simply becomes less interesting, and portion sizes naturally shrink.
Who Should Use Wegovy?
Wegovy is licensed by the EMA for adults whose BMI is 30 or above (obesity), or 27 or above with at least one weight-related condition. Eligible weight-related conditions include type 2 diabetes, pre-diabetes, high blood pressure, high cholesterol, sleep apnoea, polycystic ovary syndrome (PCOS), and cardiovascular disease. Eligibility is confirmed during your consultation by your reviewing doctor.
Wegovy Dosing Schedule
Wegovy uses a gradual five-step titration to minimise side effects while building tolerance. Each step lasts four weeks:
- Weeks 1–4: 0.25 mg weekly (starter dose)
- Weeks 5–8: 0.5 mg weekly
- Weeks 9–12: 1 mg weekly
- Weeks 13–16: 1.7 mg weekly
- Week 17+: 2.4 mg weekly (maintenance dose)
The maintenance dose of 2.4 mg is taken indefinitely while you remain on treatment. If side effects are bothersome at any step, your doctor may slow titration by holding at a lower dose for an extra month.
How to Inject Wegovy
Wegovy comes as a pre-filled disposable injector pen with a built-in needle. Each pen contains four weekly doses (at your current dose strength). You inject under the skin in your abdomen, thigh, or upper arm — same day each week, with or without food. The injection itself takes only a few seconds and is generally painless.
Side Effects of Wegovy
Most side effects are gastrointestinal and resolve within 2–4 weeks of each dose increase:
- Nausea (most common, ~44% during titration)
- Diarrhoea or constipation
- Vomiting or stomach discomfort
- Reduced appetite (intended effect)
- Fatigue, headache, dizziness
To minimise nausea: eat smaller, more frequent meals, avoid greasy or rich foods, stay well hydrated, and inject in the evening if you find nausea most pronounced in the morning.
Serious side effects are rare, but contact your doctor immediately if you experience: severe abdominal pain (possible pancreatitis or gallbladder problem), persistent vomiting, vision changes, signs of low blood sugar (if you have diabetes), or symptoms of an allergic reaction. Wegovy is contraindicated in patients with personal or family history of medullary thyroid cancer (MTC) or MEN 2 syndrome.
What Results Can You Expect?
Clinical trial data shows the following average results on Wegovy 2.4 mg:
- 5% body weight loss by week 20
- 10% body weight loss by week 40
- 14.9% body weight loss by week 68 (maintenance)
Individual results vary based on starting weight, adherence, diet, exercise, and individual biology. About one in three patients lose more than 20% of starting body weight; one in three lose 10–20%; the remainder see smaller but still meaningful losses.
Wegovy vs. Ozempic vs. Mounjaro
A frequently asked question — and an important one. Wegovy and Ozempic both contain semaglutide, the same active ingredient. The differences:
- Wegovy is licensed specifically for weight loss and reaches the higher 2.4 mg dose
- Ozempic is licensed for type 2 diabetes and tops out at 2 mg
- Mounjaro contains tirzepatide (a different molecule that targets both GLP-1 and GIP) and produces greater average weight loss (~20.9% vs ~14.9%)
Your doctor will recommend the best fit for your medical profile, history of previous weight loss medications, and personal goals.
How to Buy Wegovy Online from EU Slim Store
- Complete the free five-minute consultation form
- A Dutch BIG-registered doctor reviews your case within 24 hours
- If appropriate, your doctor issues a prescription
- Our IGJ-registered pharmacy dispenses your Wegovy in original Novo Nordisk packaging
- PostNL delivery in 3–5 working days — temperature-controlled, discreet packaging
You only pay if approved. No commitment until your doctor confirms eligibility.
Storage of Wegovy
Store unopened Wegovy pens in the refrigerator (2–8 °C) in the original carton. Do not freeze. After first use, pens can be kept at room temperature (below 30 °C) for up to 28 days. Always check the solution before injecting — discard if cloudy or discoloureds.
Pricing
Wegovy from EU Slim Store starts at €99 per month, all-inclusive. Pricing includes the medication, doctor consultation, pharmacy dispensing, ongoing monitoring, and PostNL delivery. No hidden fees.
Take the Next Step
Start your free eligibility consultation now. Get a response from a licensed doctor within 24 hours.
English 
German 
Spanish 
Dutch 
Polish 
French 
Norwegian
There are no reviews yet.